Gene: ABCG2 ×
Source: BEFREE ×
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs2231137
rs2231137
ABCG2
0.010 GeneticVariation BEFREE However, more reliable data are required to confirm the associations between the ABCG2 C421A and ABCG2 G34A polymorphisms and the toxicity of gefitinib in NSCLC patients. 29440914

2018
dbSNP: rs2231142
rs2231142
ABCG2
0.010 GeneticVariation BEFREE However, more reliable data are required to confirm the associations between the ABCG2 C421A and ABCG2 G34A polymorphisms and the toxicity of gefitinib in NSCLC patients. 29440914

2018
dbSNP: rs3114020
rs3114020
ABCG2
0.010 GeneticVariation BEFREE Further stepwise regression analysis suggested that rs3114020</span> was an independent risk f</span>actor for the prognosis of NSCLC. 26951883

2017
dbSNP: rs2725264
rs2725264
ABCG2
0.010 GeneticVariation BEFREE Our data suggest ABCG2 htSNPs r</span>s2725264 (overall group and taxane-platinum combination group) and rs4148149 (gemcitabine-platinum combination group) were associated with OS in unresectable NSCLC patients treated with first-line platinum-based chemotherapy. 23689644

2015
dbSNP: rs4148149
rs4148149
ABCG2
0.010 GeneticVariation BEFREE Our data suggest ABCG2 htSNPs rs2725264 (overall group and taxane-platinum combination group) and rs4148149 (gemcitabine-platinum combination group) were associated with OS in unresectable NSCLC patients treated with first-line platinum-based chemotherapy. 23689644

2015